Daniel Rhee, M.D., M.P.H., pediatric surgeon and surgical director of the Pediatric Surgical Oncology Program at Johns Hopkins Children’s Center, discusses neuroblastoma, a complex cancer that requires a multidisciplinary treatment team. Neuroblastoma is rare, with only 700–800 new cases diagnosed in the U.S. per year, but it is the most common solid tumor seen in children. Dr. Rhee and his team are experienced clinicians dedicated to each child’s individual treatment plan. #PediatricNeuroblastoma #JohnsHopkins
Learn more about the pediatric surgical oncology program at https://www.hopkinsmedicine.org/health/treatment-tests-and-therapies/general-pediatric-surgery/pediatric-surgical-oncology-treatments-and-doctors.
0:03 What is Neuroblastoma?
0:52 How common is it for children to be diagnosed with neuroblastoma?
1:21 What are the symptoms of neuroblastoma?
2:02 What kind of treatments are used for neuroblastoma?
3:19 What is the role of the surgeon in managing neuroblastoma?
4:24 What should the parents expect for the treatment of neuroblastoma at Johns Hopkins?
Video